Based in the US, YOU(th) specializes in innovative health assessment technologies that empower individuals by providing rapid insights into their overall…
Based in the US, YOU(th) specializes in innovative health assessment technologies that empower individuals by providing rapid insights into their overall wellness through advanced smartphone applications.YOU(th) was founded in 2023 in New York, US, to develop tools for health assessments. In February 2026, the company raised USD 4.5 mn in a funding round led by CallistoHealth GmbH, with participation from Antler, Moonstone, adesso ventures, and individual investors. The founder's history and prior ventures are not publicly available.YOU(th) offers a suite of innovative health assessment tools that utilize smartphone technology to screen over 50 biomarkers in under two minutes. Core products include facial video analysis, voice recording evaluations, external eye image assessments, and skin health photography, all driven by advanced AI algorithms. These services are designed to provide insights into various health metrics, targeting individual consumers and health institutions such as longevity clinics and health insurance providers, aiming to provide health data access to approximately 8 billion people globally.YOU(th) operates on a direct-to-consumer subscription model, allowing users access to comprehensive health monitoring services. This model encourages ongoing engagement and enables clients to utilize a proprietary wellness scoring system based on data captured via smartphone. Pricing plans are structured to provide flexible service levels tailored to user needs, facilitating continuous health tracking and personalized recommendations.With the recent funding of USD 4.5 mn raised in February 2026, YOU(th) plans to enhance product development and expand its engineering, data science, and medical research teams. The company aims to introduce new products in the health assessment domain, focusing on expanding its reach into global markets, although specific regions for expansion have not been disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in